Medical Device Investing Viveve Submits Investigational Device Exemption to FDA to Conduct LIBERATE-U.S. Trial for Improvement of Stress Urinary Incontinence
Inspire Medical Systems Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Medical Device Investing ChroMedX Reports on HemoPalm Techno-Commercial Analysis and Productization Plan
UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients
Medical Device Investing Inspire Medical Systems Announces Filing of Registration Statement for Proposed Initial Public Offering
Medical Device Investing ChroMedX CEO Lahav Gil Invited to Speak on Industry Panel at bioTEC, Biotechnology and Bioengineering Conference
Medical Device Investing ChroMedX Accelerates Software Development and Implementation Activities; Appoints iGAL Roytblat, Formerly of Kangaroo Group, as CTO, Amid Expansion
Medical Device Investing iCAD Granted CE Mark Approval in Europe for PowerLook Tomo Detection 2.0 Artificial Intelligence Solution
Medical Device Investing SeaSpine Announces Fourth Quarter and Full-Year 2017 Results and Issues 2018 Financial Guidance
